Thu. 28 Mar 2024, 7:15am ET
Benzinga
Earnings, News
Galera Therapeutics (NASDAQ:GRTX) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.35) by 71.43 percent. This is a 82.76 percent increase over losses of $(0.58) per share from the same period last year.